Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $95.8300 (3.59%) ($95.8300 - $95.8300) on Mon. May. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.4% (three month average) | RSI | 36 | Latest Price | $95.8300(3.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -5.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(58%) IWC(56%) IWN(55%) | Factors Impacting LGND price | LGND will decline at least -1.7% in a week (0% probabilities). VIXM(-23%) UUP(-19%) VXX(-16%) TBT(-6%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.7% (StdDev 3.4%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $83.5(-12.87%) | Resistance Level | $102.45 | 5 Day Moving Average | $93.7(2.27%) | 10 Day Moving Average | $96.65(-0.85%) | 20 Day Moving Average | $102.45(-6.46%) | To recent high | -23.4% | To recent low | 3.6% | Market Cap | $1.54b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |